DK52182A - Fremgangsmaade og mellemprodukter til fremstilling af pirbuterol og analoge forbindelser - Google Patents

Fremgangsmaade og mellemprodukter til fremstilling af pirbuterol og analoge forbindelser

Info

Publication number
DK52182A
DK52182A DK52182A DK52182A DK52182A DK 52182 A DK52182 A DK 52182A DK 52182 A DK52182 A DK 52182A DK 52182 A DK52182 A DK 52182A DK 52182 A DK52182 A DK 52182A
Authority
DK
Denmark
Prior art keywords
pirbuterol
preparation
intermediate products
analogical
compounds
Prior art date
Application number
DK52182A
Other languages
English (en)
Other versions
DK157541C (da
DK157541B (da
Inventor
Jr B W Cue
S S Massett
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK52182A publication Critical patent/DK52182A/da
Priority to DK180986A priority Critical patent/DK180986A/da
Publication of DK157541B publication Critical patent/DK157541B/da
Application granted granted Critical
Publication of DK157541C publication Critical patent/DK157541C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK052182A 1981-02-09 1982-02-08 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser DK157541C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK180986A DK180986A (da) 1981-02-09 1986-04-21 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23292381A 1981-02-09 1981-02-09
US23292381 1981-02-09

Publications (3)

Publication Number Publication Date
DK52182A true DK52182A (da) 1982-09-17
DK157541B DK157541B (da) 1990-01-22
DK157541C DK157541C (da) 1990-06-11

Family

ID=22875140

Family Applications (1)

Application Number Title Priority Date Filing Date
DK052182A DK157541C (da) 1981-02-09 1982-02-08 Fremgangsmaade til fremstilling af pirbuterol og analoge forbindelser

Country Status (26)

Country Link
EP (4) EP0058072A3 (da)
JP (4) JPS57150665A (da)
KR (1) KR860000623B1 (da)
AR (4) AR231439A1 (da)
AT (2) ATE21691T1 (da)
AU (1) AU530826B2 (da)
CA (1) CA1179677A (da)
CS (1) CS229678B2 (da)
DD (2) DD210034A5 (da)
DE (2) DE3272061D1 (da)
DK (1) DK157541C (da)
EG (1) EG16242A (da)
ES (4) ES509430A0 (da)
FI (1) FI820396L (da)
GR (1) GR75867B (da)
GT (1) GT198273686A (da)
IE (2) IE52326B1 (da)
IL (1) IL64954A (da)
NO (4) NO820371L (da)
NZ (1) NZ199646A (da)
PH (4) PH20622A (da)
PL (4) PL130580B1 (da)
PT (1) PT74397B (da)
SU (4) SU1194273A3 (da)
YU (3) YU42756B (da)
ZA (1) ZA82778B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615293A1 (de) * 1986-05-06 1987-11-12 Bayer Ag Verwendung von heteroarylethylaminen zur leistungsfoerderung bei tieren, heteroarylethylamine und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
BE795937A (fr) * 1972-03-01 1973-08-27 Pepro Procede d'hydroxymethylation d'une 3-hydroxy-pyridine substituee
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US4031108A (en) * 1974-10-09 1977-06-21 Pfizer Inc. 2-Hydroxymethyl-3-benzyloxypyridine-6-epoxyethane
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
DK157541C (da) 1990-06-11
AR229712A1 (es) 1983-10-31
YU201984A (en) 1985-04-30
JPS57150665A (en) 1982-09-17
JPS6059231B2 (ja) 1985-12-24
DD202544A5 (de) 1983-09-21
ES8305721A1 (es) 1983-04-16
ES518972A0 (es) 1984-03-01
YU42908B (en) 1988-12-31
YU43389B (en) 1989-06-30
EP0058071A2 (en) 1982-08-18
IL64954A (en) 1986-03-31
FI820396L (fi) 1982-08-10
IL64954A0 (en) 1982-04-30
EP0058071B1 (en) 1986-07-23
CA1179677A (en) 1984-12-18
ES8403112A1 (es) 1984-03-01
NZ199646A (en) 1985-11-08
JPS6119624B2 (da) 1986-05-17
ES518973A0 (es) 1984-03-01
NO820371L (no) 1982-08-10
ES8403110A1 (es) 1984-03-01
IE820275L (en) 1982-08-09
PL130918B1 (en) 1984-09-29
GR75867B (da) 1984-08-02
PL130580B1 (en) 1984-08-31
KR860000623B1 (ko) 1986-05-24
PL239426A1 (en) 1983-04-25
PT74397B (en) 1984-10-09
NO824274L (no) 1982-08-10
EP0058072A3 (en) 1982-08-25
AU8027182A (en) 1982-08-19
AU530826B2 (en) 1983-07-28
PL239428A1 (en) 1983-04-25
DK157541B (da) 1990-01-22
SU1250170A3 (ru) 1986-08-07
AR229373A1 (es) 1983-07-29
PH19167A (en) 1986-01-16
IE52326B1 (en) 1987-09-16
ATE21691T1 (de) 1986-09-15
JPS6059911B2 (ja) 1985-12-27
PL130917B1 (en) 1984-09-29
PH19164A (en) 1986-01-16
PL239427A1 (en) 1983-04-25
ATE20882T1 (de) 1986-08-15
EP0058069A2 (en) 1982-08-18
YU26682A (en) 1985-04-30
EP0058072A2 (en) 1982-08-18
CS229678B2 (en) 1984-06-18
EP0058069B1 (en) 1986-08-27
ZA82778B (en) 1983-01-26
EP0058070A3 (en) 1982-08-25
KR830009028A (ko) 1983-12-17
SU1217253A3 (ru) 1986-03-07
YU201884A (en) 1985-04-30
SU1240354A3 (ru) 1986-06-23
DD210034A5 (de) 1984-05-30
PH20622A (en) 1987-03-06
JPS6135184B2 (da) 1986-08-12
NO824275L (no) 1982-08-10
DE3272793D1 (en) 1986-10-02
YU42756B (en) 1988-12-31
AR231439A1 (es) 1984-11-30
PT74397A (en) 1982-03-01
PL130678B1 (en) 1984-08-31
SU1194273A3 (ru) 1985-11-23
DE3272061D1 (en) 1986-08-28
ES518971A0 (es) 1984-03-01
GT198273686A (es) 1983-07-30
JPS6193164A (ja) 1986-05-12
EP0058070A2 (en) 1982-08-18
PL235000A1 (en) 1983-04-11
IE820273L (en) 1982-08-09
EG16242A (en) 1989-01-30
ES509430A0 (es) 1983-04-16
AR229374A1 (es) 1983-07-29
ES8403111A1 (es) 1984-03-01
EP0058071A3 (en) 1982-08-25
IE52325B1 (en) 1987-09-16
JPS60208964A (ja) 1985-10-21
NO824273L (no) 1982-08-10
JPS60208962A (ja) 1985-10-21
PH20292A (en) 1986-11-18
EP0058069A3 (en) 1982-09-01

Similar Documents

Publication Publication Date Title
DK159672C (da) Fremgangsmaade og apparat til fremstilling af soft-ice
DK154185D0 (da) Fremgangsmaade og apparat til fremstilling af granulater
DK280182A (da) Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK261782A (da) Overfladebehandlingsmetode og praeparat til cement
DK529479A (da) Fremgangsmaade og apparat til stoerkning af metal
DK158701C (da) Fremgangsmaade og apparat til fremstilling af konfekture-produkter
DK436981A (da) Fremgangsmaade til fremstilling af 25-hydroxy26,26,26,27,27,27,-hexafluor-cholecalciferol og mellemprodukter herved
DK552582A (da) Fremgangsmaade og apparat til fremstilling af poseformede indpakninger
DK149385D0 (da) Apparat og fremgangsmaade til fremstilling af ispinde
IS2700A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
DK39281A (da) Fremgangsmaade til fremstilling af 17alfa-acyloxy-5beta-corticoider og 17alfa-acyloxy-5alfa-corticoider
DK384183A (da) Mordenit og fremgangsmaade til fremstilling deraf
DK271582A (da) Fremgangsmaade og komposition til fremstilling af asbestfrie genstande
DK118981A (da) Asbestfrit glasfiberarmeret blandingscementprodukt og fremgangsmaade til fremstilling af dette
DK370582A (da) Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK555881A (da) Forstaerket ketsjerramme og fremgangsmaade til fremstilling af samme
DK160744C (da) Oxychloreringskatalysator-praekursor til oxychlorering og fremgangsmaade til fremstilling heraf
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
DK485182A (da) Fremgangsmaade til fremstilling af cement og apparat til udoevelse af fremgangsmaaden
DK156509C (da) Fremgangsmaade og indretning til fremstilling af cement
DK52182A (da) Fremgangsmaade og mellemprodukter til fremstilling af pirbuterol og analoge forbindelser
IS1271B6 (is) Aðferð og tæki til þess að rétta við flatfisk
DK158363C (da) Fremgangsmaade og anlaeg til fremstilling af isomerose
DK154033C (da) Fremgangsmaade og apparat til fremstilling af et sammensat isolerende profil
DK21384D0 (da) Benzendiol-komposition og fremgangsmade til dens fremstilling

Legal Events

Date Code Title Description
PUP Patent expired